Each PDA Technical Advisory Board:
These issues may include proposed regulations, technical guidance documents, inspection procedures, policy statements, Pharmacopoeia proposals, standards setting activities, and other related items developed by the global regulatory bodies (e.g. US FDA,EMA, WHO, USP, ANVISA).
For more information or to suggest a topic for PDA commenting, please contact Ruth Miller, PDA Director of Regulatory Affairs, [email protected].